Meloidogyne Incognita Management using Fumigant and Non-fumigant Nematicides on Sweet Potato
© 2022 Liu and Grabau. published by Sciendo.
Veröffentlicht in: | Journal of nematology. - 1969. - 54(2022), 1 vom: 12. Feb., Seite 20220026 |
---|---|
1. Verfasser: | |
Weitere Verfasser: | |
Format: | Online-Aufsatz |
Sprache: | English |
Veröffentlicht: |
2022
|
Zugriff auf das übergeordnete Werk: | Journal of nematology |
Schlagworte: | Journal Article 1,3-dichloropropene Ipomoea batatas Meloidogyne incognita fluazaindolizine fluopyram free-living nematode fumigant management nematicide mehr... |
Zusammenfassung: | © 2022 Liu and Grabau. published by Sciendo. Southern root-knot nematode (SRKN, Meloidogyne incognita) is a major pest of sweet potato, and nematicides are needed to manage this nematode. The objectives of this study were to assess the efficacy of fluazaindolizine, a new non-fumigant nematicide, in comparison with the fumigant nematicide 1,3-dichloropropene (1,3-D) and non-fumigant nematicides fluopyram and oxamyl for (1) SRKN management, (2) impacts on free-living nematodes, and (3) sweet potato yield in field trials. Among all nematicides, 1,3-D at 84 kg/ha most consistently (2 of 3 years) managed SRKN soil populations and improved yield. Fluazaindolizine at 2.24 kg/ha and fluazindolizine at 1.12 kg/ha plus oxamyl at 2.14 kg/ha managed SRKN populations and improved yield in 1 of 3 years, whereas fluazaindolizine alone at 1.12 kg/ha only decreased SRKN populations. Fluopyram at 238 g/ha did not affect SRKN or yield. Nematicide application also had non-target effects on free-living nematodes with 1,3-D reducing abundances relative to untreated most frequently (2018 and 2020), but other nematicides also reducing free-living nematode abundances in 2020. In summary, 1,3-D is the most consistent option for SRKN control on sweet potato, but fluazaindolizine, oxamyl or combinations of the two products can also be effective |
---|---|
Beschreibung: | Date Revised 18.08.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
ISSN: | 0022-300X |
DOI: | 10.2478/jofnem-2022-0026 |